Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
63 words
A vaccine which is protective against avian polyomavirus infection in a bird which is classified as being a member of the Psittaciformes order, comprising an immunogenic amount of a modified live avian polyomavirus, wherein the immunogenic amount of the modified live avian polyomavirus corresponds to a titer of between 10 2 TCID 50 and 10 7 TCID 50 and a pharmaceutically acceptable carrier.
Claim 2
Dependent Claim
63 words
A vaccine which is protective against avian polyomavirus infection in a bird which is classified as being a member of the Psittaciformes order, comprising an immunogenic amount of a modified live avian polyomavirus, wherein the immunogenic amount of the modified live avian polyomavirus corresponds to a titer of between 10 2 TCID 50 and 10 7 TCID 50 and a pharmaceutically acceptable carrier.
Claim 3
Dependent Claim
29 words
The vaccine of claim 1, wherein the immunogenic amount of the modified live avian polyomavirus corresponds to a titer of about 10 4 TCID 50 for the avian polyomavirus.
Claim 4
Dependent Claim
11 words
The vaccine of claim 1, wherein the bird is a Budgerigar.
Claim 5
Dependent Claim
11 words
The vaccine of claim 1, wherein the bird is a Cockatiel.
Claim 6
Dependent Claim
11 words
The vaccine of claim 1, wherein the bird is a lovebird.
Claim 7
Independent Claim
43 words
A method of preventing avian polyomavirus infection in a bird which is classified as being a member of the Psittaciformes order, comprising administering to the bird a vaccine comprising an immunogenic amount of a modified live avian polyomavirus and a pharmaceutically acceptable carrier.
Claim 8
Independent Claim
43 words
A method of preventing avian polyomavirus infection in a bird which is classified as being a member of the Psittaciformes order, comprising administering to the bird a vaccine comprising an immunogenic amount of a modified live avian polyomavirus and a pharmaceutically acceptable carrier.
Claim 9
Dependent Claim
34 words
The method of claim 6, wherein the immunogenic amount of the modified live avian polyomavirus corresponds to a titer of between 10 2 TCID 50 and 10 7 TCID 50 for the avian polyomavirus.
Claim 10
Dependent Claim
31 words
The method of claim 7, wherein the immunogenic amount of the modified live avian polyomavirus corresponds to a titer of about 10 4 TCID 50 for the avian polyomavirus before inactivation.
Claim 11
Dependent Claim
11 words
The method of claim 6, wherein the bird is a Budgerigar.
Claim 12
Dependent Claim
11 words
The method of claim 6, wherein the bird is a Cockatiel.
Claim 13
Dependent Claim
11 words
The method of claim 6, wherein the bird is a lovebird.
Claim 14
Dependent Claim
16 words
The method of claim 6, further comprising administering at least one booster vaccine to the bird.